コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 development of the neurodegenerative disease Friedreich's ataxia.
2 yndrome 2 (HDL2), familial prion disease and Friedreich's ataxia.
3 triggering neuro- and cardiodegeneration in Friedreich's ataxia.
4 a GAA/TTC DNA triplex has been implicated in Friedreich's ataxia.
5 clinical trials in Huntington's disease and Friedreich's ataxia.
6 tract as possibly related to the etiology of Friedreich's ataxia.
7 es neural and cardiac cell degeneration, and Friedreich's ataxia.
8 re tightly associated with the occurrence of Friedreich's ataxia.
9 function of this unusual DNA conformation in Friedreich's ataxia.
10 sease-associated repeats except for those of Friedreich's ataxia.
11 evant to the development of therapeutics for Friedreich's ataxia.
12 ataxin protein as related to the etiology of Friedreich's ataxia.
13 otonic dystrophy, the fragile X syndrome and Friedreich's ataxia.
14 implicated in the neurodegenerative disease, Friedreich's ataxia.
15 g fragile X syndrome, myotonic dystrophy and Friedreich's ataxia.
16 pathologic process leading to cell damage in Friedreich's ataxia.
17 xia and peripheral neuropathy that resembles Friedreich's ataxia.
18 human disorders, such as Menkes disease and Friedreich's ataxia.
19 al, and behavioural deficits associated with Friedreich's ataxia.
20 n, anthracycline-induced cardiotoxicity, and Friedreich's ataxia.
21 to guide upcoming clinical trial designs in Friedreich's ataxia.
22 mice could provide mechanistic insights into Friedreich's ataxia.
23 (EFACTS) investigates the natural history of Friedreich's ataxia.
24 kdown of FDX2 may be a potential therapy for Friedreich's ataxia.
25 ophy is similar to findings in patients with Friedreich's ataxia.
26 modifying, and neuroprotective treatment for Friedreich's ataxia.
27 t strain of cells characterizing the disease Friedreich's Ataxia.
28 r data to inform upcoming clinical trials in Friedreich's ataxia.
29 ility and its implications for diseases like Friedreich's ataxia.
30 -S cluster assembly lead to diseases such as Friedreich's ataxia.
31 factor (SCF) in a humanized murine model of Friedreich's ataxia.
32 s in the first intron of the FXN gene causes Friedreich's ataxia.
33 Nov 21, 2013, we enrolled 605 patients with Friedreich's ataxia.
34 or the design of upcoming clinical trials of Friedreich's ataxia.
35 egistry investigating the natural history of Friedreich's ataxia.
36 A, fragile X syndrome, Hunter syndrome, and Friedreich's ataxia.
37 ohort of patients with genetically confirmed Friedreich's ataxia.
38 ters but whose mutations are associated with Friedreich's ataxia.
39 strophy, Huntington's disease, fragile X and Friedreich's ataxia.
40 y of high-dose nicotinamide in patients with Friedreich's ataxia.
41 and frataxin (FXN), the protein deficient in Friedreich's ataxia.
42 assembly process and the molecular basis of Friedreich's ataxia.
43 for causing the neurodegenerative pathology Friedreich's ataxia.
44 AA repeats responsible for the human disease Friedreich's ataxia.
45 tosomal recessive neurodegenerative disorder Friedreich's ataxia.
46 s in the first intron of FXN gene results in Friedreich's ataxia.
47 egulate the FXN gene silencing, which causes Friedreich's ataxia.
48 in a hereditary neurodegenerative disorder, Friedreich's ataxia.
49 pinocerebellar ataxias 1, 2, 3, 6 and 7, and Friedreich's ataxia, 132 sporadic idiopathic and 33 clin
53 mitochondrial protein which is deficient in Friedreich's ataxia, a hereditary neurodegenerative dise
54 ataxin overexpression in a cellular model of Friedreich's ataxia, a neurodegenerative disease caused
56 repeats that silence frataxin expression in Friedreich's ataxia, a terminal neurodegenerative diseas
57 ra-mitochondrial frataxin in the etiology of Friedreich's ataxia, also have important implications fo
59 Low expression of frataxin in humans causes Friedreich's ataxia, an autosomal recessive neurodegener
61 long with common phenotypic traits shared by Friedreich's ataxia and FXTAS carriers (e.g. gait ataxia
63 orrelated with the neurodegenerative disease Friedreich's ataxia and results in the inactivation of F
64 n the other hand, revealed that pathology in Friedreich's ataxia and spinocerebellar ataxia type 3 is
65 hy of the cerebellar nuclei in patients with Friedreich's ataxia and spinocerebellar ataxia type 3.
66 tology shows marked atrophy of the nuclei in Friedreich's ataxia and spinocerebellar ataxia type 3.
67 r understanding of the multisystem nature of Friedreich's ataxia and the development of targeted trea
68 aining to activation of frataxin expression (Friedreich's ataxia) and production of active survival m
69 ng those associated with fragile X syndrome, Friedreich's ataxia, and Huntington's disease, and corre
70 spinocerebellar ataxia type 6, preserved in Friedreich's ataxia, and mildy reduced in spinocerebella
71 with autosomal dominant congenital cataract, Friedreich's ataxia, and X-linked sideroblastic anemia w
74 AA)(n) repeat expansions are responsible for Friedreich's ataxia as well as late-onset cerebellar ata
76 o explain the reduction in mRNA abundance in Friedreich's ataxia based on intermolecular triplex form
77 lled 592 patients with genetically confirmed Friedreich's ataxia between Sept 15, 2010, and April 30,
79 reduced in spinocerebellar ataxia type 6 and Friedreich's ataxia compared to matched controls (P-valu
80 t expansions found in myotonic dystrophy and Friedreich's ataxia confer variegation of expression on
84 onal Institute for Health Research, European Friedreich's Ataxia Consortium for Translational Studies
85 repeat sequences, such as (GAA)n repeats in Friedreich's ataxia, (CTG)n repeats in myotonic dystroph
93 a diagnosis by Nikolaus Friedreich in 1863, Friedreich's ataxia (FA) is an autosomal recessive progr
97 otein frataxin (FXN) causes the rare disease Friedreich's ataxia (FA), for which there is no successf
99 9 was recently 'excluded' as a candidate for Friedreich's ataxia following the identification of an e
100 cations for the design of clinical trials in Friedreich's ataxia, for which SARA might be the most su
101 nded GAA*TTC repeat sequence associated with Friedreich's ataxia (FRDA) adopts non-B DNA structures,
103 isms of reduced frataxin (FXN) expression in Friedreich's ataxia (FRDA) are linked to epigenetic modi
104 peats in intron 1 of the frataxin gene cause Friedreich's ataxia (FRDA) by reducing frataxin mRNA lev
105 Our discovery that plasmids containing the Friedreich's ataxia (FRDA) expanded GAA.TTC sequence, wh
139 in stem cell-derived endothelial cells from Friedreich's ataxia (FRDA), a genetic disease of FXN def
140 ure is the most common cause of mortality in Friedreich's ataxia (FRDA), a mitochondrial disease char
143 to influence the clinical manifestations of Friedreich's ataxia (FRDA), an autosomal recessive neuro
144 reduce the expression of frataxin and cause Friedreich's ataxia (FRDA), an autosomal recessive neuro
145 characterize the myocardium in patients with Friedreich's ataxia (FRDA), and the relationship between
158 of the mitochondrial protein frataxin causes Friedreich's ataxia (FRDA); the mechanism by which this
159 enrolled patients with genetically confirmed Friedreich's ataxia from 11 European study sites in Aust
160 rimental system to analyze the mutability of Friedreich's ataxia (GAA)(n) repeats during chronologica
164 rch, as outlined by the recently established Friedreich's Ataxia Global Clinical Consortium, which co
165 n a parent does not exclude the diagnosis of Friedreich's ataxia in the offspring, and tests for the
179 The progressive neurodegenerative disease Friedreich's ataxia is caused by a decreased level of ex
185 rs in Htt.Q111 Huntington's disease and YG8s Friedreich's ataxia mice resulted in efficient editing i
186 n = 12, age range 41-76 years, five female), Friedreich's ataxia (n = 12, age range 21-55 years, seve
187 years), whereas patients with Danon disease, Friedreich's ataxia, Noonan syndrome, and PRKAG2 cardiom
188 ply, due to diminished assembly as occurs in Friedreich's ataxia or defective distribution, causes se
190 s, consistent with a multi-step mechanism of Friedreich's ataxia pathophysiology, and suggesting alte
191 modulate the effects of oxidative stress on Friedreich's ataxia patients and, more in general, on ot
197 oteins include mutations of frataxin causing Friedreich's ataxia, PINK1, DJ1 causing Parkinson's dise
199 netically confirmed FA and baseline modified Friedreich's Ataxia Rating Scale (mFARS) scores between
202 TTC triplet repeats (responsible for DM1 and Friedreich's ataxia, respectively) can expand by genetic
205 human subjects caused by the genetic disease Friedreich's ataxia results in decreased mitochondrial f
206 g1/MTP1, Sfxn1 and DCYTB: Ongoing studies of Friedreich's ataxia, sideroblastic anemia, aceruloplasmi
207 in the homozygous state in atypical cases of Friedreich's ataxia, such as older age of onset, preserv
208 irst intron of the X25 (frataxin) gene cause Friedreich's ataxia, the most common inherited ataxia.
211 comparing spinocerebellar ataxia type 6 and Friedreich's ataxia to matched controls (P < 0.01, boots
214 emale patients (aged 18 years or older) with Friedreich's ataxia were given single doses (phase 1) an
215 ty-six patients with a clinical diagnosis of Friedreich's ataxia were investigated for the GAA trinuc
217 deficiency of this protein in humans causes Friedreich's ataxia, while its complete absence in yeast
218 function have a role in the pathogenesis of Friedreich's ataxia, Wilson's disease and hereditary spa
219 ry outcome, 190 (95 per group) patients with Friedreich's ataxia would be needed, and fewer patients